Stellar Pharmaceuticals Inc., a Canadian pharmaceutical developer and marketer of cost effective products for select healthcare markets, projected today that its second quarter revenues will surpass one million dollars, an approximate 55% increase over revenues reported for the same quarter in 2008. The company also anticipates that it will be profitable for the period.

Peter Riehl, Stellar’s President and CEO, stated, “This is the strongest second quarter in the Company’s history, with revenues up substantially in all markets. The Company expects to also be profitable for the period, making this the third consecutive quarter that the Company has shown a profit. We are very pleased to see this growth given the challenging economic times.”